NewAmsterdam PharmaNAMS
那斯達克 · USD
27.87
+0.09
(+0.32%)
收盤 08/22 03:59 (UTC+8)
08/22 03:59 (UTC+8)
NewAmsterdam PharmaNAMS
27.87
+0.09
(+0.32%)
財務數據
損益表
- 0.01
- 0.02
- 0.29
- 0.13
- 0.03
- 0.19
- 0.00
- 0.00
- 0.03
- 0.04
- 74.47
- 62.67
- 1177.36
- -56.13
- -76.68
- 542.88
- -98.18
- -90.80
- 9400.00
- 21.74
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | 3,701 | 3,040 | 32 | 348 | 19,145 | 2,978 | 12,772 | 29,111 | 2,279 | 1,401 |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | 3,701 | 3,040 | 32 | 348 | - | - | 12,772 | 29,111 | - | 1,401 |
營業費用 | 68,565 | 61,460 | 66,012 | 55,491 | 54,780 | 71,903 | 59,206 | 54,114 | 54,854 | 56,883 |
研發費用 | 41,673 | 38,009 | 38,594 | 30,971 | 27,516 | 44,751 | 34,895 | 35,702 | 38,379 | 42,430 |
推銷及管理費用 | 26,892 | 23,451 | 27,418 | 24,520 | 27,264 | 27,152 | 24,311 | 18,412 | 16,475 | 14,453 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -64,864 | -58,420 | -65,980 | -55,143 | -35,635 | -68,925 | -46,434 | -25,003 | -52,575 | -55,482 |
其他收入及費用 | - | - | - | - | - | - | - | - | - | - |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -64,135 | -48,441 | -74,923 | -72,005 | -17,364 | -39,527 | -92,177 | -16,648 | -39,007 | -93,767 |
所得稅 | - | - | - | - | - | - | - | -1 | - | - |
稅後純益 | -64,135 | -48,441 | -74,923 | -72,005 | -17,364 | -39,527 | -92,177 | -16,647 | -39,007 | -93,767 |
基本每股稅後盈餘(元) | -0.55 | -0.40 | -0.62 | -0.61 | -0.15 | -0.34 | -0.91 | -0.18 | -0.41 | -1.06 |
稀釋每股稅後盈餘(元) | -0.55 | -0.40 | -0.62 | -0.61 | -0.15 | -0.34 | -0.91 | -0.18 | -0.41 | -1.06 |
基本平均股數(千股) | 117651.00 | 121716.00 | 126063.00 | 119000.00 | 112509.00 | 116124.00 | 99587.00 | 94754.00 | 94711.00 | 88380.00 |
稀釋平均股數(千股) | 117651.00 | 121716.00 | 126063.00 | 119000.00 | 112509.00 | 116124.00 | 99587.00 | 94754.00 | 94711.00 | 88380.00 |
還原基本每股稅後盈餘(元) | -0.55 | -0.40 | -0.62 | -0.61 | -0.15 | -0.34 | -0.91 | -0.18 | -0.41 | -1.06 |
還原稀釋每股稅後盈餘(元) | -0.55 | -0.40 | -0.62 | -0.61 | -0.15 | -0.34 | -0.91 | -0.18 | -0.41 | -1.06 |
還原基本平均股數(千股) | 117,651 | 121,716 | 126,063 | 119,000 | 112,509 | 116,124 | 99,587 | 94,754 | 94,711 | 88,380 |
還原稀釋平均股數(千股) | 117,651 | 121,716 | 126,063 | 119,000 | 112,509 | 116,124 | 99,587 | 94,754 | 94,711 | 88,380 |
EBITDA(千元) | -64,076 | -48,379 | -74,864 | -71,941 | -17,319 | -39,475 | -92,126 | -16,620 | -38,988 | -93,752 |